Sanofi Innovation Award 2025: Novel Approaches in Type 2 Inflammation With this award, Sanofi supports residents and senior physicians who are clinically active in allergology/clinical immunology in Switzerland and whose translational scientific work deals with the topic of type 2 inflammation and related diseases.The award is endowed with CHF 15’000 and is intended for the execution of a scientific project.
The AIU 2026 will be held from Friday, January 23rd (noon) to Saturday, January 24th (evening).
More information will follow.
This site uses cookies. Some of these cookies require your explicit consent. Please accept the use of cookies in order to use all functions.
To the privacy policy